| Kertara Ellerbe, | |
|
5560 Ackerfield Ave, Long Beach, CA 90805-4958 | |
| (562) 477-6599 | |
| Not Available |
| Full Name | Kertara Ellerbe |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 5560 Ackerfield Ave, Long Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548024995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 714456 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kertara Ellerbe, 5560 Ackerfield Ave, Long Beach, CA 90805-4958 Ph: () - | Kertara Ellerbe, 5560 Ackerfield Ave, Long Beach, CA 90805-4958 Ph: (562) 477-6599 |
News Archive
Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug.
Today's hospitals are under pressure to enhance patient care and streamline workflow while containing costs. To achieve this goal, Florida Hospital Fish Memorial acquired four XarioXG ultrasound systems from Toshiba America Medical Systems, Inc., to create imaging consistency across various departments.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, today reported financial results for the three and six months ended June 30, 2015.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
› Verified 7 days ago
Mr. Alvis L Johnson Ii, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1775 Chestnut Ave, Long Beach, CA 90813 Phone: 562-599-4444 Fax: 310-679-2920 | |
Domenica Coronel, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1225 Bennett Ave, Apt. 308, Long Beach, CA 90804 Phone: 310-938-4460 | |
Marcia Freeman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Grand Ave, Long Beach, CA 90815 Phone: 562-972-2676 | |
Innocent Goueth, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1775 Chestnut Ave, Long Beach, CA 90813 Phone: 562-599-8444 | |
Carla Dale Jones-alt, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2401 San Anseline Ave, Long Beach, CA 90815 Phone: 562-596-8777 | |
Amaryllis Gilbert, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1501 Hughes Way Ste 100, Long Beach, CA 90810 Phone: 310-221-6336 |